For AD patients carrying APOE4, elevated hydroxyl radicals in the blood (Ihara et al. 2000) and decreased cerebral oxygen consumption (Robb et al. 2022) have been observed, and neurons expressing APOE4 demonstrate reduced ATP production (Orr et al. 2019). Here, APOE is linked to Alzheimer disease.